H.R. 4392 · 115th Congress
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
- Stage
- In committee
- Sponsor
- David McKinley
- Introduced
- 2017-11-14
- Latest action
- 2017-11-17 · Referred to the Subcommittee on Health.
Summary
This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.